|From: hunter1 (Rep: 457)||Date: 04/15/2019 20:09|
|Forum: Wall Street Pit - Msg #2783091 - List PRTO msgs ||Thread #674076591 (Rec: 0) |
|WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its plans to explore a range of strategic options to enhance shareholder value.|
Having missed statistical significance on both co-primary endpoints in PATENCY-2, Proteon’s second Phase 3 trial of investigational vonapanitase, the Board of Directors has decided to explore all strategic alternatives for Proteon and is reducing its employee headcount and spending on operations in order to preserve its cash resources.
any stock i buy or sell could be halted and go to zero at any time.if you can not lose it dont trade it.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.